Table 3. Response to osimertinib.
Mutation | CR/PR | SD/PD | P value |
---|---|---|---|
Activating EGFR mutation | 0.001 | ||
Not detectable | 37 (75.5%) | 1 (12.5%) | |
Detectable | 12 (24.5%) | 7 (87.5%) | |
T790M mutation | 1.0 | ||
Not detectable | 42 (86%) | 7 (87.5%) | |
Detectable | 7 (14%) | 1 (12.5%) |
EGFR, epidermal growth factor receptor; CR, complete response; PR, partial response; SD, stable disease; PD, disease progression.